- Global Pharma News & Resources

Anti-Obesity Prescription Drugs Market Survey | Demand, Supply, Premiumization, Performance, Inflation & Forecast 2028

The “Global Anti-Obesity Prescription Drugs Market 2019” report is a demanding study of the market represent the state-of-the-art details in the market. It also forecast its growth in the next few years. The Anti-Obesity Prescription Drugs report access several aspects that discover the growth as well as the volume of the Global Anti-Obesity Prescription Drugs Market.

Obesity is a medical condition in which excess body fat get saturated into human body to the level that it may have adverse impact on health. Obesity results from a combination of causes and individual factors such as behavior and genetics. Behaviors can include dietary patterns, limited physical activity, medication use, and other exposures. Body Mass Index (BMI) is a method used for measuring obesity among people.

Request for Sample Report @

Anti-Obesity Prescription Drugs Market Report Information: Global anti-obesity prescription drugs market segmentation by mechanism of action: Incretin mimetics/GLP-1 agonists, SNDRIs, Lipase inhibitors, Serotonin receptor agonists, Sympathomimetic-GABA receptor agonists, Sympathomimetics, Others (human Glucagon-like peptide-1 analog, inhibitors of dopamine & noradrenalin etc.). Global anti-obesity prescription drugs market segmentation by target site: Peripherally acting anti-obesity drugs, Centrally acting anti-obesity drugs. Global anti-obesity prescription drugs market segmentation, by therapy: Monotherapies, Polytherapies. Global anti-obesity prescription drugs market segmentation, by end user: Hospital, Clinics, Pharmacies – Global Forecast to 2028

It Also Includes a Number of Top Key Players:

Vivus Inc.
Zafgen Inc.
Norgine bv
Boehringer Ingelheim GmbH. and Bristol-Myers Squibb Co.
Takeda Pharmaceutical.
Eisai Company.
GlaxoSmithKline plc.
Pfizer Inc.
Shionogi USA

The Global Anti-Obesity Prescription Drugs Market is Segmented on the Basis of Regions:

01. North America ( United States)

02. Europe ( Germany, France, UK)

03. Asia-Pacific ( China, Japan, India)

04. Latin America ( Brazil)

05. Middle East & Africa

Key Highlights from Anti-Obesity Prescription Drugs Market Study:

01. Revenue and Sales Analysis — Historical Revenue and sales size is presented and further data is triangulated with top-down and bottom-up come near to forecast fulfilled market size and to evaluate forecast numbers for key regions covered in the report along with confidential and well identified types and end-use industry. Additionally macroeconomic factor and regulatory policies are ascertained in Anti-Obesity Prescription Drugs industry evolution and predictive analysis.

02.Manufacturing Analysis — This report is currently inspect regarding various product type and application. The Anti-Obesity Prescription Drugs Market give a chapter spotlighting manufacturing process analysis approve by primary data collected by Industry experts and Key officials of profiled companies.

03. Competition — Leading players have been studied depending on their company profile, product case, volume, product/service price, sales & profit.

04. Demand & Supply and Effectiveness — Anti-Obesity Prescription Drugs report also provides distribution, Production, Consumption & EXIM** (Export & Import). ** If applicable.

Have Any Query? Ask Our Experts @

In the end, the report avails market players with such game-changing recommendations which helps them to improve their business accordingly and maximize their profits. It also provides profitable business plans and making informed decisions for the future.

Contact Us At:

Mr. Benni Johnson

MarketResearch.Biz (Powered By Prudour Pvt. Ltd.)

420 Lexington Avenue, Suite 300

New York City, NY 10170,

United States

Tel: +1 347 826 1876


Email ID:

Editor Details

Last Updated: 31-Jul-2019